Craft

Shanghai Medicilon

Stock Price

¥36.9

2024-10-29

Market Capitalization

¥4.7 B

2024-10-29

Revenue

¥1.2 B

FY, 2025

Shanghai Medicilon Summary

Company Summary

Overview
Shanghai Medicilon (美迪西生物医药) is a contract research organization (CRO) that provides biopharmaceutical preclinical research and development solutions. Its services cover the whole process of preclinical new drug research, mainly including drug discovery, pharmaceutical research, and preclinical research. The company serves pharmaceutical and scientific research institutions.
Type
Public
Status
Active
Founded
2004
HQ
Shanghai, CN | view all locations
Website
https://www.medicilon.com.cn/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Shanghai, Shang Hai Shi HQ

    China

    No. 585, Chuanda Road

Shanghai Medicilon Financials

Summary Financials

Revenue (FY, 2025)
¥1.2B
Gross profit (FY, 2025)
¥200.3M
Net income (FY, 2025)
(¥167.8M)
Cash (FY, 2025)
¥249.7M
EBIT (FY, 2025)
(¥187.2M)
Enterprise value
$4.9B

Footer menu